NASDAQ
Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology. It offers Prime Editors with a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase enzyme; and a pegRNA, which targets the Prime Editor to a specific genomic location and provides a template for making the desired edit to the target DNA sequence. The company was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.
Open
$4.28
Previous Close
$4.23
Day High
$4.37
Day Low
$4.12
52 Week High
$6.94
52 Week Low
$1.11
No price data available for this timeframe.